Global Product Manager, GE Healthcare Life Sciences
BIOGRAPHY
FEB 20, 2017 8:00 AM PST
Improve and optimize quantitative Western blotting
Presented at:
Protein Research Live
Speaker
Abstract
The aim with this session is to give a brief overview of various parameters that you need to consider when deciding your strategy how to obtain quantitative data.
You May Also Like
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
NOV 15, 2023 | 10:00 AM
Join our webinar to discover how automated sample preparation can free your lab from the time-consuming, costly, and complex manual workflows in proteomics. In the ever-evolving field of pro...
DEC 13, 2023 | 9:00 AM
The quest for digital excellence in today’s biotech research laboratories demands modern software acquisition, robust protection protocols, and a keen eye on evolving security requirem...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
FEB 20, 2017 8:00 AM PST
Share
Improve and optimize quantitative Western blotting
Presented at:
Protein Research Live
Loading Comments...
Finish Registering
-
APR 30, 2024Immuno-Oncology Virtual Event Series 2024 -
MAY 07, 20243rd International Biosecurity Virtual Symposium
-
SEP 03, 2024Microbiology Week Virtual Event Series 2024
- See More
-
APR 18, 2024
- See More
